These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 34830785)

  • 21. Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma.
    Steinmann K; Sandner A; Schagdarsurengin U; Dammann RH
    Oncol Rep; 2009 Dec; 22(6):1519-26. PubMed ID: 19885608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease.
    Gollin SM
    Genes Chromosomes Cancer; 2014 Dec; 53(12):972-90. PubMed ID: 25183546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients.
    Kostareli E; Hielscher T; Zucknick M; Baboci L; Wichmann G; Holzinger D; Mücke O; Pawlita M; Del Mistro A; Boscolo-Rizzo P; Da Mosto MC; Tirelli G; Plinkert P; Dietz A; Plass C; Weichenhan D; Hess J
    Epigenetics; 2016; 11(1):61-73. PubMed ID: 26786582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy.
    Canning M; Guo G; Yu M; Myint C; Groves MW; Byrd JK; Cui Y
    Front Cell Dev Biol; 2019; 7():52. PubMed ID: 31024913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients' survival, immune cell infiltrates, mutational load, and interferon γ signature.
    Sailer V; Sailer U; Bawden EG; Zarbl R; Wiek C; Vogt TJ; Dietrich J; Loick S; Grünwald I; Toma M; Golletz C; Gerstner A; Kristiansen G; Bootz F; Scheckenbach K; Landsberg J; Dietrich D
    EBioMedicine; 2019 Oct; 48():341-352. PubMed ID: 31628024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation.
    Severino P; Brüggemann H; Andreghetto FM; Camps C; Klingbeil Mde F; de Pereira WO; Soares RM; Moyses R; Wünsch-Filho V; Mathor MB; Nunes FD; Ragoussis J; Tajara EH
    BMC Cancer; 2013 Nov; 13():533. PubMed ID: 24209638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of tobacco in the development of head and neck squamous cell carcinoma in an eastern Indian population.
    Basu R; Mandal S; Ghosh A; Poddar TK
    Asian Pac J Cancer Prev; 2008; 9(3):381-6. PubMed ID: 18990006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive analysis of DNA methylation in head and neck squamous cell carcinoma indicates differences by survival and clinicopathologic characteristics.
    Colacino JA; Dolinoy DC; Duffy SA; Sartor MA; Chepeha DB; Bradford CR; McHugh JB; Patel DA; Virani S; Walline HM; Bellile E; Terrell JE; Stoerker JA; Taylor JM; Carey TE; Wolf GT; Rozek LS
    PLoS One; 2013; 8(1):e54742. PubMed ID: 23358896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma.
    Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Schootman M; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2018 Aug; 144(8):727-737. PubMed ID: 30027284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns.
    Aggarwal N; Yadav J; Thakur K; Bibban R; Chhokar A; Tripathi T; Bhat A; Singh T; Jadli M; Singh U; Kashyap MK; Bharti AC
    Front Cell Infect Microbiol; 2020; 10():537650. PubMed ID: 33344262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of head and neck squamous cell cancer biomarkers.
    Polanska H; Raudenska M; Gumulec J; Sztalmachova M; Adam V; Kizek R; Masarik M
    Oral Oncol; 2014 Mar; 50(3):168-77. PubMed ID: 24382422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPV status-independent association of alcohol and tobacco exposure or prior radiation therapy with promoter methylation of FUSSEL18, EBF3, IRX1, and SEPT9, but not SLC5A8, in head and neck squamous cell carcinomas.
    Bennett KL; Lee W; Lamarre E; Zhang X; Seth R; Scharpf J; Hunt J; Eng C
    Genes Chromosomes Cancer; 2010 Apr; 49(4):319-26. PubMed ID: 20029986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced Radiation Sensitivity of Human Papillomavirus-Driven Head and Neck Cancer: Focus on Immunological Aspects.
    Özcan-Wahlbrink M; Schifflers C; Riemer AB
    Front Immunol; 2019; 10():2831. PubMed ID: 31849993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter methylation of galanin receptors as epigenetic biomarkers for head and neck squamous cell carcinomas.
    Kanazawa T; Misawa K; Shinmura K; Misawa Y; Kusaka G; Maruta M; Sasaki T; Watanabe Y; Carey TE
    Expert Rev Mol Diagn; 2019 Feb; 19(2):137-148. PubMed ID: 30640567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of Human Papilloma Virus and Risk Factors among Patients with Head and Neck Squamous Cell Carcinoma Attending a Tertiary Referral Centre in South India.
    Bandhary SK; Shetty V; Saldanha M; Gatti P; Devegowda D; R PS; Shetty AK
    Asian Pac J Cancer Prev; 2018 May; 19(5):1325-1330. PubMed ID: 29802694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
    Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
    BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preferential activation of the hedgehog pathway by epigenetic modulations in HPV negative HNSCC identified with meta-pathway analysis.
    Fertig EJ; Markovic A; Danilova LV; Gaykalova DA; Cope L; Chung CH; Ochs MF; Califano JA
    PLoS One; 2013; 8(11):e78127. PubMed ID: 24223768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Head and Neck Squamous Cell Carcinoma: Epigenetic Landscape.
    Romanowska K; Sobecka A; Rawłuszko-Wieczorek AA; Suchorska WM; Golusiński W
    Diagnostics (Basel); 2020 Dec; 11(1):. PubMed ID: 33375464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.